STVN
Stevanato Group SpA
NYSE · Healthcare · Medical - Instruments & Supplies · IT
$18.75
−2.60%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$19.27
From 52W high−32.09%
Volume131073.00
Market cap$5.12B
P/E (TTM)34.8x
P/S (TTM)3.7x
Div yield0.33%
Key dataOct 16, 2026
Open
$19.27
From 52W high
−32.09%
Volume
131073.00
Market cap
$5.12B
ValuationView details →
P/E (Fwd)
24.5x
EV/EBITDA
16.6x
P/E (TTM)
34.8x
RSI (14)
28.7
MomentumView details →
1D Return
−2.60%
YTD Return
−7.65%
SummaryUpdated Jun 1, 2026
Stevanato Group S.p.A. (NYSE:STVN) is an Italian pharmaceutical packaging and equipment company founded in 1949 and headquartered in Piombino Dese, Italy. The company went public in July 2021 and operates as a subsidiary of Stevanato Holding S.R.L. Stevanato has evolved from a traditional glass manufacturer into a leading provider of integrated solutions for the pharmaceutical and healthcare industries, specializing in drug containment, delivery systems, and manufacturing equipment. The company serves global pharmaceutical companies through manufacturing facilities in Italy, the United States, and other international locations.
Similar companies
Latest newsMore news →
Stevanato Group divested its California-based subsidiary Balda C. Brewer, and updated its full-year outlook to reflect this divestiture.68d agoStevanato Group reported an 8% increase in revenue to €302.0 million for the second quarter of 2026, with high-value solutions representing 45% of total revenue.73d agoStevanato Group announced that liraglutide combination products using its Alina pen injector received marketing authorizations in multiple European countries.78d ago